Browse the corpus

Epinastine is a medication used in the treatment and management of allergic conjunctivitis. This activity reviews the indications, contraindications, activity, adverse events, and other key elements of epinastine therapy in the clinical setting related to the essential points needed by members of an interprofessional team managing the care of patients with allergic reactions conjunctivitis and its related conditions and sequelae. Objectives: Identify the mechanism of action of epinastine. Describe the potential adverse effects of epinastine. Review the appropriate monitoring for patients receiving therapy with epinastine. Outline interprofessional team strategies for improving care coordination and communication to advance epinastine and improve outcomes. Access free multiple choice questions on this topic.

There are no reported cases of overdose with epinastine to date. However, in case of an overdose, the institution and health care providers must act promptly to ensure airway patency and that there is no circulatory collapse.

Anti-histamines have been the mainstay for the treatment of allergic conditions. Epinastine is a mast cell stabilizer as well as an anti-histaminic, which the FDA has approved for topical use to relieve various allergic conditions. Since epinastine does not possess any CNS toxicity, it is superior to other anti-histamines with sedative properties. An accurate diagnosis is necessary before prescribing epinastine. Any clinician can prescribe epinastine, and the patient must be monitored regularly for adverse outcomes. Patients should be encouraged to follow the treatment plan; this requires an interprofessional team effort from the clinicians (including specialists, NPs, PAs, and optometrists), nursing staff, and pharmacists, coordinating efforts and communicating across interprofessional lines to improve and enhance patient care outcomes. [Level 5]